The Melbourne Biomedical Precinct Partners have identified eight priority research platforms to position it in the global top 10. They reflect the Precinct’s clinical research strengths, as well as global health and disease trends and the future of science and discovery. Importantly, they also provide some of the greatest opportunities for commercialisation.
While it is recognised these are not all the research platforms of the Melbourne Biomedical Precinct, this prioritisation helps guide the long term direction of Precinct Partners and help focus cooperation and alliances in and beyond the Precinct.